Company news
Cvrx, Inc. (NASDAQ:CVRX) news
Every Cvrx, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
CVRx Responds to Letter from Pointillist Family Office
August 25, 2026
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
August 24, 2026
Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Co...
August 24, 2026
CVRx Announces Sales Leadership Transition
August 11, 2026
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
July 28, 2026
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
July 23, 2026
CVRx Announces Chief Financial Officer Transition
June 9, 2026
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 27, 2026
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
May 20, 2026
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy
May 14, 2026
CVRx Reports First Quarter 2026 Financial and Operating Results
May 11, 2026
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Popul...
May 4, 2026
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
April 27, 2026
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
April 20, 2026
CVRx Reports Preliminary First Quarter 2026 Financial Results
April 13, 2026
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
March 2, 2026
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
February 12, 2026
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026
January 29, 2026
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
January 22, 2026
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance
January 12, 2026
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy
January 6, 2026
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 22, 2025
CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
CVRx Reports Third Quarter 2025 Financial and Operating Results
November 5, 2025
CVRx to Present at the Jefferies Global Healthcare Conference in London
November 4, 2025
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
October 22, 2025
CVRx Reports Second Quarter 2025 Financial and Operating Results
August 4, 2025
CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference
July 29, 2025
CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025
July 21, 2025
CVRx Announces Positive News on Outpatient Payment for Barostim
July 16, 2025
CVRx to Present at the William Blair 45th Annual Growth Stock Conference
May 28, 2025
CVRx Reports First Quarter 2025 Financial and Operating Results
May 8, 2025
CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025
April 24, 2025
CVRx Reports Preliminary First Quarter 2025 Financial Results
April 7, 2025
CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim
February 12, 2025
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
February 4, 2025
CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025
January 21, 2025
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
January 13, 2025
CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference
November 20, 2024
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025
November 4, 2024
CVRx Reports Third Quarter 2024 Financial and Operating Results
October 29, 2024
CVRx announces new CPT® Category I codes for Barostim
October 18, 2024
CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024
October 15, 2024
CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim
September 12, 2024
CVRx Announces Appointment of Two New Board Members
September 3, 2024
CVRx Announces Increased Inpatient Payment for Barostim Procedure
August 2, 2024
CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference
July 31, 2024
CVRx Reports Second Quarter 2024 Financial and Operating Results
July 29, 2024
CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024
July 15, 2024